An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In VivoFelix Schiele, Herbert Nar, John Park et al.|Journal of Molecular Biology|2013Cited by 35
Potent Cholesteryl Ester Transfer Protein Inhibitors of Reduced Lipophilicity: 1,1′-Spiro-Substituted Hexahydrofuroquinoline DerivativesThomas Trieselmann, Herbert Nar, Holger Wagner et al.|Journal of Medicinal Chemistry|2014Cited by 27
An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels<em> in vivo</em>Felix Schiele, Herbert Nar, John E. Park et al.|DORA PSI (Paul Scherrer Institute)|2014Cited by 0